TransThera Sciences (Nanjing), Inc. (HKG:2617)
Hong Kong · Delayed Price · Currency is HKD 10.94
+0.82 (8.10%)
Sep 30, 2026, 4:08 PM HKT
HKG:2617 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Net Income | -268.56 | -295.96 | -274.61 | -343.39 | -251.94 |
Depreciation & Amortization | 4.07 | 4.74 | 6.17 | 7.14 | 8.74 |
Other Amortization | 0.29 | 0.29 | 0.27 | 0.26 | 0.24 |
Loss (Gain) From Sale of Assets | -0.05 | 0 | 0 | 0 | 0.01 |
Loss (Gain) From Sale of Investments | -0.3 | -2.95 | -10.65 | -14.09 | -14.28 |
Stock-Based Compensation | 14.59 | 15.06 | 16.39 | 14.78 | 7.01 |
Other Operating Activities | 5.79 | -0.56 | -0.23 | -11.62 | -33.85 |
Change in Inventory | 0 | -0.04 | -0.01 | 0.09 | -0.09 |
Change in Accounts Payable | 3.21 | 22.86 | 2.67 | 6.34 | 33.58 |
Change in Unearned Revenue | - | - | - | -1.17 | -0.12 |
Change in Other Net Operating Assets | -10.16 | 3.06 | -11.17 | 22.33 | 13.82 |
Operating Cash Flow | -251.13 | -253.51 | -271.18 | -319.33 | -236.89 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Capital Expenditures | -0.81 | -0.16 | -0.77 | -3.49 | -2.02 |
Sale of Property, Plant & Equipment | - | - | 0 | - | 0 |
Sale (Purchase) of Intangibles | - | - | - | -8.3 | -7.81 |
Investment in Securities | -312.43 | -67.83 | 349.19 | -178.66 | 221.06 |
Other Investing Activities | - | - | - | 3.51 | -2 |
Investing Cash Flow | -313.24 | -68 | 348.42 | -186.94 | 209.23 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Long-Term Debt Repaid | - | -2.68 | -3.24 | -3.51 | -2.09 |
Lease Payments | -2.42 | -2.68 | -3.24 | -3.51 | -2.09 |
Net Debt Issued (Repaid) | -2.42 | -2.68 | -3.24 | -3.51 | -2.09 |
Issuance of Common Stock | 551.48 | 172.2 | - | 20 | 240 |
Other Financing Activities | -0.34 | -0.53 | -1.64 | -0.73 | -2.47 |
Financing Cash Flow | 548.73 | 169 | -4.87 | 15.76 | 235.44 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Foreign Exchange Rate Adjustments | -8.17 | -1.58 | 0.51 | 3.2 | 27.52 |
Net Cash Flow | -23.81 | -154.1 | 72.88 | -487.31 | 235.3 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Free Cash Flow | -251.93 | -253.68 | -271.96 | -322.81 | -238.91 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -710.57% | - | - | -27333.78% | -192667.74% |
Free Cash Flow Per Share | -0.63 | -0.65 | -0.71 | -0.85 | -0.66 |
Levered Free Cash Flow | -157.67 | -141.08 | -163.77 | -53.02 | - |
Unlevered Free Cash Flow | -157.59 | -141 | -163.65 | -52.87 | - |
Free Cash Flow After Leases | -254.35 | -256.35 | -275.19 | -326.32 | -241 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Change in Working Capital | -6.95 | 25.88 | -8.52 | 27.59 | 47.19 |